AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $133,952 | +13.3% | 10,665 | 0.0% | 0.15% | +0.7% |
Q1 2023 | $118,275 | -9.2% | 10,665 | 0.0% | 0.15% | -16.9% |
Q4 2022 | $130,220 | -10.2% | 10,665 | -23.5% | 0.18% | -15.6% |
Q3 2022 | $145,000 | +4.3% | 13,946 | 0.0% | 0.21% | +22.7% |
Q2 2022 | $139,000 | +37.6% | 13,946 | 0.0% | 0.17% | +41.0% |
Q1 2022 | $101,000 | -42.3% | 13,946 | -7.9% | 0.12% | -29.5% |
Q4 2021 | $175,000 | – | 15,141 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 21,719,191 | $226,748,000 | 8.80% |
Perceptive Advisors | 27,372,917 | $285,773,000 | 8.29% |
Palo Alto Investors LP | 9,847,774 | $102,811,000 | 8.13% |
Finepoint Capital LP | 1,688,400 | $17,627,000 | 5.80% |
CM Management, LLC | 450,000 | $4,698,000 | 5.24% |
Avoro Capital Advisors LLC | 26,800,000 | $279,792,000 | 5.17% |
Artal Group S.A. | 4,000,000 | $41,760,000 | 1.78% |
Kynam Capital Management, LP | 676,849 | $7,066,000 | 1.49% |
Ghost Tree Capital, LLC | 500,000 | $5,220,000 | 1.46% |
Boxer Capital, LLC | 2,325,000 | $24,273,000 | 1.36% |